Shendong Yuan

668 total citations
20 papers, 524 citations indexed

About

Shendong Yuan is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shendong Yuan has authored 20 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shendong Yuan's work include Signaling Pathways in Disease (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Computational Drug Discovery Methods (3 papers). Shendong Yuan is often cited by papers focused on Signaling Pathways in Disease (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Computational Drug Discovery Methods (3 papers). Shendong Yuan collaborates with scholars based in United States, Saudi Arabia and China. Shendong Yuan's co-authors include Judi Bryant, Brad O. Buckman, Marc Adler, Marc Whitlow, Guo‐Zhen Ji, Hui Ding, Zhan‐Ting Li, Mingdeng Wei, Chen Huang and Cheng‐Xue Zhao and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and The Journal of Organic Chemistry.

In The Last Decade

Shendong Yuan

20 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shendong Yuan United States 11 253 176 88 77 62 20 524
M. Paola Castaldi United States 12 494 2.0× 349 2.0× 100 1.1× 69 0.9× 18 0.3× 20 857
Mark Cornebise United States 11 207 0.8× 203 1.2× 140 1.6× 37 0.5× 83 1.3× 12 606
Alan G. Olivero United States 13 312 1.2× 200 1.1× 89 1.0× 29 0.4× 19 0.3× 26 618
René Hersperger Switzerland 14 470 1.9× 194 1.1× 55 0.6× 32 0.4× 95 1.5× 19 687
Christopher J. Rito United States 11 428 1.7× 178 1.0× 44 0.5× 52 0.7× 22 0.4× 13 621
Darin E. Jones United States 20 297 1.2× 373 2.1× 69 0.8× 47 0.6× 20 0.3× 44 796
Keigo Gohda Japan 15 294 1.2× 104 0.6× 271 3.1× 38 0.5× 25 0.4× 50 676
Carl Crysler United States 19 304 1.2× 325 1.8× 145 1.6× 20 0.3× 166 2.7× 37 782
Mark Salvati United States 15 399 1.6× 191 1.1× 174 2.0× 44 0.6× 60 1.0× 48 1.0k

Countries citing papers authored by Shendong Yuan

Since Specialization
Citations

This map shows the geographic impact of Shendong Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shendong Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shendong Yuan more than expected).

Fields of papers citing papers by Shendong Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shendong Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shendong Yuan. The network helps show where Shendong Yuan may publish in the future.

Co-authorship network of co-authors of Shendong Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Shendong Yuan. A scholar is included among the top collaborators of Shendong Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shendong Yuan. Shendong Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bultinck, Jennyfer, Shendong Yuan, Ludovico Cantuti‐Castelvetri, et al.. (2025). NLRP3 inhibition by VTX3232 tempers inflammation resulting in reduced body weight, hyperglycemia, and hepatic steatosis in obese male mice. Molecular Metabolism. 103. 102282–102282. 1 indexed citations
2.
Sandborn, William J., Kathleen M. Ogilvie, Fei Liu, et al.. (2023). 43073 Pharmacokinetics, Safety and Pharmacodynamics of VTX2735, A Potent and Selective NLRP3 Inhibitor, In Healthy Adult Volunteers. Journal of the American Academy of Dermatology. 89(3). AB206–AB206. 2 indexed citations
3.
Chen, Karen, Artur K. Mailyan, Jeffrey J. Jackson, et al.. (2019). Total Synthesis of Covalent Cysteine Protease Inhibitor N-Desmethyl Thalassospiramide C and Crystallographic Evidence for Its Mode of Action. Organic Letters. 21(2). 508–512. 3 indexed citations
4.
Islam, Imadul, Shendong Yuan, Christopher W. West, et al.. (2018). Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorganic & Medicinal Chemistry Letters. 28(20). 3372–3375. 4 indexed citations
5.
Islam, Imadul, Shendong Yuan, Wei Xu, et al.. (2018). Reversible, orally available ADP receptor (P2Y12) antagonists Part I: Hit to lead process. Bioorganic & Medicinal Chemistry Letters. 28(9). 1459–1463. 7 indexed citations
6.
Ren, Zhao, Danny Tam, Ying‐zi Xu, et al.. (2013). Development of a Novel β-Secretase Binding Assay Using the AlphaScreen Platform. SLAS DISCOVERY. 18(6). 695–704. 6 indexed citations
7.
Xu, Ying‐zi, Shendong Yuan, Simeon Bowers, et al.. (2013). Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(10). 3075–3080. 21 indexed citations
8.
Bowers, Simeon, Ying‐zi Xu, Shendong Yuan, et al.. (2013). Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates. Bioorganic & Medicinal Chemistry Letters. 23(7). 2181–2186. 10 indexed citations
9.
West, Christopher W., Marc Adler, Elena Ho, et al.. (2009). Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Bioorganic & Medicinal Chemistry Letters. 19(19). 5712–5715. 11 indexed citations
10.
Bryant, Judi, Joseph Post, Yixin Wang, et al.. (2008). Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (I): In vitro effects on platelets. Thrombosis Research. 122(4). 523–532. 26 indexed citations
11.
Adler, Marc, Brad O. Buckman, Judi Bryant, et al.. (2008). Structures of potent selective peptide mimetics bound to carboxypeptidase B. Acta Crystallographica Section D Biological Crystallography. 64(2). 149–157. 17 indexed citations
12.
Whitlow, Marc, Marc Adler, David D. Davey, et al.. (2007). The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase. Bioorganic & Medicinal Chemistry Letters. 17(9). 2505–2508. 6 indexed citations
13.
Islam, Imadul, Greg Brown, Judi Bryant, et al.. (2007). Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517. Bioorganic & Medicinal Chemistry Letters. 17(14). 3819–3825. 35 indexed citations
14.
Adler, Marc, David D. Davey, Elena Ho, et al.. (2007). 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation. Bioorganic & Medicinal Chemistry Letters. 17(9). 2499–2504. 8 indexed citations
15.
Nagashima, Mariko, Jon Vincelette, Shendong Yuan, et al.. (2007). A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) – Part I: Pharmacological characterization. Thrombosis and Haemostasis. 97(1). 45–53. 29 indexed citations
16.
Islam, Imadul, Judi Bryant, Karen May, et al.. (2006). 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorganic & Medicinal Chemistry Letters. 17(5). 1349–1354. 25 indexed citations
17.
Feldman, Richard I., James M. Wu, Mark A. Polokoff, et al.. (2005). Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1. Journal of Biological Chemistry. 280(20). 19867–19874. 171 indexed citations
18.
Adler, Marc, Judi Bryant, Brad O. Buckman, et al.. (2005). Crystal Structures of Potent Thiol-Based Inhibitors Bound to Carboxypeptidase B,. Biochemistry. 44(26). 9339–9347. 26 indexed citations
19.
Li, Zhan‐Ting, Guo‐Zhen Ji, Cheng‐Xue Zhao, et al.. (1999). Self-Assembling Calix[4]arene [2]Catenanes. Preorganization, Conformation, Selectivity, and Efficiency. The Journal of Organic Chemistry. 64(10). 3572–3584. 110 indexed citations
20.
Li, Zhan‐Ting, et al.. (1998). The self-assembly of catenated calix[4]arenes. Tetrahedron Letters. 39(36). 6517–6520. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Paola Castaldi Breakdown of academic impact, for papers by Mark Cornebise Breakdown of academic impact, for papers by Alan G. Olivero Breakdown of academic impact, for papers by René Hersperger Breakdown of academic impact, for papers by Christopher J. Rito Breakdown of academic impact, for papers by Darin E. Jones Breakdown of academic impact, for papers by Keigo Gohda Breakdown of academic impact, for papers by Carl Crysler Breakdown of academic impact, for papers by Mark Salvati
Rankless by CCL
2026